Scientific News Boston Scientific S Next Level Long Term Plans Why 2 Analysts Boost Price Targets
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific S Next Level Long Term Plans Why 2 Analysts Boost Price Targets is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
UBS Boosts Boston Scientific (BSX) Price Target After Strong Q3 Earnings
Boston Scientific Corporation (NYSE:BSX) ranks among the best long-term stocks to buy according to D. E. Shaw. On October 23, UBS maintained its Buy rating on Boston Scientific Corporation (NYSE:BSX) ... Read More
Boston Scientific Up 7% in a Month: How Should You Play the Stock?
Shares of Boston Scientific BSX have climbed 7% over the past 30 days, extending their positive year-to-date momentum. The stock’s performance has outpaced its industry’s 0.9% gains, the broader ... Read More
A Look Into Boston Scientific Inc's Price Over Earnings
Compared to the aggregate P/E ratio of the 53.83 in the Health Care Equipment & Supplies industry, Boston Scientific Inc. has a lower P/E ratio of 52.97. Shareholders might be inclined to think that ... Read More
Boston Scientific rises as cardiology sales drive Q3 beat, guidance boost
Boston Scientific (NYSE:BSX) traded higher on Wednesday after the MedTech giant exceeded Street forecasts with its Q3 2025 results and boosted its full-year outlook following better-than-expected ... Read More
What to Expect from Boston Scientific's Earnings
Boston Scientific (NYSE:BSX) is gearing up to announce its quarterly earnings on Wednesday, 2025-10-22. Here's a quick overview of what investors should know before the release. Analysts are ... Read More
Boston Scientific: Not In The Most Resolute State As It Approaches Q3 Earnings
Boston Scientific, which was faring relatively well over the first 8 months of the year, appears to have lost its footing of late and is now trading below all its key moving averages. The upcoming Q3 ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus